期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 26, 期 4, 页码 767-778出版社
IOS PRESS
DOI: 10.3233/JAD-2011-110512
关键词
Alzheimer's disease; amyloid-beta degradation; amyloid-beta efflux; antioxidant
资金
- National Institute of Aging (NIA) [AG016029, AG031846]
- National Heart, Lung, and Blood Institute [HL088141]
- University of Alabama at Birmingham School of Public Health
- Alzheimer's Association [IIRG-09-131791]
- American Health Assistance Foundation [A2010328]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088141] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R03AG016029, R01AG031846] Funding Source: NIH RePORTER
Alzheimer's disease (AD) is a major cause of dementia in the elderly with no effective treatment. Accumulation of amyloid-beta peptide (A beta) in the brain, one of the pathological features of AD, is considered to be a central disease-causing and disease-promoting event in AD. In this study, we showed that feeding male A beta PP/PS1 transgenic mice, a well established mouse model of AD, with a diet containing phenolic antioxidant tert-butylhydroquinone (TBHQ) dramatically reduced brain A beta load with no significant effect on the amounts of alpha-and beta-C-terminal fragments or full-length A beta PP. Further studies showed that TBHQ diet inhibited the expression of plasminogen activator inhibitor-1 (PAI-1), a protease inhibitor which plays a critical role in brain A beta accumulation in AD, accompanied by increases in the activities of tissue type and urokinase type plasminogen activators (tPA and uPA) as well as plasmin. Moreover, we showed that TBHQ diet increased the expression of low density lipoprotein related protein-1, a multi ligand endocytotic receptor involved in transporting A beta out of the brain, and plasma A beta(40) and A beta(42) levels. We also showed that TBHQ diet increased the concentration of glutathione, an important antioxidant, and suppressed the expression of NADPH oxidase 2 as well as lipid peroxidation. Collectively, our data suggest that TBHQ may have therapeutic potential for AD by increasing brain antioxidant capacity/reducing oxidative stress level and by stimulating A beta degradation/clearance pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据